Clinical Trial Update: Investigating The Potential Of A Hay-Aged Cheese To Reduce Cholesterol As Mediated By Changes In The Gut Microbiome [NA]

View source ↗

Summary

An ongoing clinical trial is evaluating whether hay-aged cheese can lower cholesterol by modifying the gut microbiome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia

Snippet

Sponsor: Anisha Wijeyesekera | Conditions: Cholesterol, Elevated | NA | Status: RECRUITING